Meaghan Bartlett

7PUBLICATIONS
21CO-AUTHORS
Molecular medicineHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 10, 2025
Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema.

Sarah Walsh, Anja Haltner, Meaghan Bartlett

|May 28, 2025
Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema.

Sarah Walsh, Meaghan Bartlett, Elizabeth M Salvo-Halloran

|May 06, 2025
One-Year Efficacy of Guselkumab Versus Advanced Therapies for the Treatment of Moderately to Severely Active Crohn's Disease: A Network Meta-Analysis.

Tim Disher, Dominik Naessens, Myrlene Sanon

|Sep 10, 2024
A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib.

Imtiaz A Samjoo, Alexandra Hall, Connie Chen

|Oct 22, 2022
Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma.

Tom Martin, Saad Z Usmani, Jordan M Schecter

|Jul 11, 2022
Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma.

Luciano J Costa, Parameswaran Hari, Jesus G Berdeja

Pageof 2

Frequent Collaborators

5 joint publications

Imtiaz A Samjoo

3 joint publications

Becky Hooper

3 joint publications

Anja Haltner

2 joint publications

Nadia Harbeck